Processa Pharmaceuticals
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
601 21st St Ste 300, Vero Beach, Florida...Phone Number
(772) 453-2899Revenue
-Stock Symbol
PCSAIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Processa Pharmaceuticals
Processa Pharmaceuticals is a development-stage company dedicated to improving the quality of life for individuals suffering from life-threatening and life-compromising chronic diseases. The company pursues a unique approach, focusing on the development, rather than the initial discovery, of pharmacological solutions, particularly in oncology and other areas with significant unmet medical needs. Their mission is to create effective treatments for patients who currently have limited or poor options. The leadership team leverages extensive experience in regulatory science and clinical development, employing a patient-centric and de-risked strategy intended to efficiently bring new therapies to market.Explore more
Processa Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Processa Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Processa Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Processa Pharmaceuticals has new funding data
Check out if Processa Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Processa Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Processa Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Processa Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Processa Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Processa Pharmaceuticals launches new products
Recommended Actions
Find VP level buyers at Processa Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Processa Pharmaceuticals
Compare insights from companies similar to Processa Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Processa Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Processa Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Processa Pharmaceuticals.
Processa Pharmaceuticals financials insights
Gather financial insights about Processa Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Debt
$2.6M
2020
Debt
$150K
2021
Share Placement
$10.2M
Processa Pharmaceuticals Tech Stack
A closer look at the technologies used by Processa Pharmaceuticals
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Funding
Funding
Project
Business Development, Pharmaceuticals
Processa Pharmaceuticals News & Media
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
Interim safety and efficacy data to be reported in Q1Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
Preliminary Phase 2 data demonstrate PCS6422+Capecitabine increased cancer-killing metabolite exposure while maintaining comparable safety to monotherapy capecitabineProcessa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025
VERO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies and innovative treatments for rare diseases, today announced that its abstract, “Adaptive Phase 2/3 Study for PCS499 (499) in Patients with Focal Segmental Glomerulosclerosis (FSGS)”, has been accepted for presentation at the American Society of Nephrology (ASN) Kidney Week 2025, taking place November 5–9,
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Processa Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Processa Pharmaceuticals is a development-stage company dedicated to improving the quality of life for individuals suffering from life-threatening and life-compromising chronic diseases. The company pursues a unique approach, focusing on the development, rather than the initial discovery, of pharmacological solutions, particularly in oncology and o... Read More
